Introduction: The Cell & Gene Therapy Manufacturing Services Market is on the verge of a significant expansion, with revenue estimated at $5.1 billion in 2022 and expected to reach a staggering $11.5 billion by 2027. This remarkable growth, at a CAGR of 17.5% from 2022 to 2027, is being fueled by various factors that are shaping the landscape of cell and gene therapy manufacturing....